Since 2010, when Botox was approved by the FDA for migraines that occur at least 15 days out of the month, Jason Krutsch, MD, has used the treatment on dozens of patients.
“Botox significantly impacts patients with chronic migraine headache,” said Dr. Krutsch, who serves as director of Interventional Pain Management at the University of Colorado Denver in the Anschutz Outpatient Pavilion. “Some benefit more than others, but in general, patients are able to function better, sleep better, mood is elevated, depression and anxiety are lessened, and migraines have decreased by nine days per month in most patients.”
Related Articles on Pain Management:
Kentucky Pain Bill Passes House
One Third of Cancer Patients Receive Inadequate Pain Treatment
The Digital Doctor: How to Harness the Internet’s Power to Enhance Patient Relationships and Practice Revenue
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
